Joseph P Balthasar

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 14

Top Topics

Diffusion Weighted

Acinetobacter Baumannii

Monoclonal Antibody

Top Venues

Molecular cancer therapeutics

International journal of molecular sciences

Journal of pharmacokinetics and pharmacodynamics

This page only lists publications with an associated author ORCID identifier.

Publications

Toan D Nguyen, Brandon M Bordeau, Joseph P Balthasar
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability. Cancers 15 (3) (2023)
Brandon M Bordeau, Toan Duc Nguyen, Joseph Ryan Polli, Ping Chen, Joseph P Balthasar
Payload-binding Fab fragments increase the therapeutic index of MMAE antibody-drug conjugates. Molecular cancer therapeutics (2023)
Toan D Nguyen, Brandon M Bordeau, Joseph P Balthasar
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability. Cancers 15 (3) (2023)
Brandon M Bordeau, Toan Duc Nguyen, Joseph Ryan Polli, Ping Chen, Joseph P Balthasar
Payload-binding Fab fragments increase the therapeutic index of MMAE antibody-drug conjugates. Molecular cancer therapeutics (2023)
Toan Duc Nguyen, Brandon M Bordeau, Joseph P Balthasar
Use of Payload Binding Selectivity Enhancers to Improve Therapeutic Index of Maytansinoid-Antibody-Drug Conjugates. Molecular cancer therapeutics (2023)
Brandon M Bordeau, Joseph Ryan Polli, Ferdinand Schweser, Hans Peter Grimm, Wolfgang F Richter, Joseph P Balthasar
Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Monoclonal Antibody Tumor Disposition. International journal of molecular sciences 23 (2) (2022)
Toan D Nguyen, Brandon M Bordeau, Yu Zhang, Anna G Mattle, Joseph P Balthasar
Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies. International journal of molecular sciences 24 (1) (2022)
Joseph Ryan Polli, Joseph P Balthasar
Cell Penetrating Peptides Conjugated to Anti-Carcinoembryonic Antigen "Catch-and-Release" Monoclonal Antibodies Alter Plasma and Tissue Pharmacokinetics in Colorectal Cancer Xenograft Mice. Bioconjugate chemistry 33 (8) (2022)
Toan D Nguyen, Brandon M Bordeau, Yu Zhang, Anna G Mattle, Joseph P Balthasar
Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies. International journal of molecular sciences 24 (1) (2022)
Ping Chen, Brandon M Bordeau, Yu Zhang, Joseph P Balthasar
Transient Inhibition of Trastuzumab-Tumor Binding to Overcome the "Binding-Site Barrier" and Improve the Efficacy of a Trastuzumab-Gelonin Immunotoxin. Molecular cancer therapeutics 21 (10) (2022)
Toan D Nguyen, Brandon M Bordeau, Yu Zhang, Anna G Mattle, Joseph P Balthasar
Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies. International journal of molecular sciences 24 (1) (2022)
Brandon M Bordeau, Joseph P Balthasar
Strategies to enhance monoclonal antibody uptake and distribution in solid tumors. Cancer biology & medicine 18 (3) (2022)
Shun Xin Wang-Lin, Ruth Olson, Janet M Beanan, Ulrike MacDonald, Thomas A Russo, Joseph P Balthasar
Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model. The Journal of pharmacology and experimental therapeutics 368 (3) (2019)
Patrick M Glassman, Joseph P Balthasar
Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies. Journal of pharmacokinetics and pharmacodynamics 43 (4) (2016)